|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/395 | |
| A61K 31/5377 | |||
| A61K 39/395 |
| (11) | Patento numeris | 2370103 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09756754.9 |
| Europos patento paraiškos padavimo data | 2009-11-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-10-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-03-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2009/065861 |
| Data | 2009-11-25 |
| (87) | Numeris | WO 2010/060939 |
| Data | 2010-06-03 |
| (30) | Numeris | Data | Šalis |
| 08170255 | 2008-11-28 | EP | |
| 08170261 | 2008-11-28 | EP |
| (72) |
GARCIA-ECHEVERRIA, Carlos, CH
JENSEN, Michael, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMBINATIONS COMPRISING AN ISOXAZOLE DERIVED HSP90-INHIBITOR AND THE HER2 INHIBITOR TRASTUZUMAB |
| PHARMACEUTICAL COMBINATIONS COMPRISING AN ISOXAZOLE DERIVED HSP90-INHIBITOR AND THE HER2 INHIBITOR TRASTUZUMAB |